TECHNOLOGY

More information about our technologies

  MIDGE

  MIDGE-Th1

  dSLIM

CONTACT

Investor & Public Relations

  Mr. Joerg Petrass

Research & Development

  Dr. Matthias Schroff

Business Development

  Ms. Arlett Killat

NEWS

Nov. 21, 2011

MOLOGEN attains the goals of the renal cancer study with MGN1601 ahead of schedule

 the press release

Nov. 18, 2011

MOLOGEN AG appoints Dr. Stefan M. Manth to the scientific advisory board

 the press release